Zealand Pharma A/S

Home » Zealand Pharma A/S

Secondary

Zealand Pharma A/S

They are a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. Currently, their shares are traded on Nasdaq Copenhagen A/S, or Nasdaq Copenhagen, under the symbol ZEAL. The closing price of our shares on Nasdaq Copenhagen on August 1, 2017 was DKK 121.50 per share, which equals a price of $19.30 per ADS based on the DKK/U.S. dollar exchange rate as of August 1, 2017.

Symbol

ZLND

Last Closing Price
$19.30

Shares
1,000,000

Anticipated Date
TBD

Underwriters
Morgan Stanley, Goldman Sachs & Co.

To view the prospectus for Zealand Pharma A/S, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253